Abivax (ABVX) Change in Cash (2024 - 2026)

Abivax's Change in Cash history runs 3 years deep, the most recent figure standing at -$46.0 million for Q1 2026.

• In Q1 2026, Change in Cash fell 7.51% year-over-year to -$46.0 million; the TTM figure through Mar 2026 stood at $439.0 million (up 396.2% YoY), while the FY2025 annual figure was $433.6 million, up 476.76% from the prior year.
• Change in Cash was -$46.0 million for Q1 2026 at Abivax, up from -$85.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $618.1 million in Q3 2025 to a low of -$85.0 million in Q4 2025.
• Historically, Change in Cash has averaged $31.1 million across 3 years, with a median of -$42.8 million in 2025.
• Biggest YoY gain for Change in Cash was 1444.43% in 2025; the steepest drop was 280.84% in 2025.
• A 3-year view of Change in Cash shows it stood at -$38.7 million in 2024, then tumbled by 119.56% to -$85.0 million in 2025, then surged by 45.89% to -$46.0 million in 2026.
• The last three Change in Cash figures came in at -$46.0 million (Q1 2026), -$85.0 million (Q4 2025), and $618.1 million (Q3 2025), per Business Quant data.